Annual Current Liabilities
$38.50 M
+$31.21 M+427.77%
December 31, 2023
Summary
- As of February 12, 2025, CTCX annual total current liabilities is $38.50 million, with the most recent change of +$31.21 million (+427.77%) on December 31, 2023.
- During the last 3 years, CTCX annual current liabilities has risen by +$22.70 million (+143.63%).
- CTCX annual current liabilities is now at all-time high.
Performance
CTCX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$6.17 M
+$396.10 K+6.86%
September 30, 2024
Summary
- As of February 12, 2025, CTCX quarterly total current liabilities is $6.17 million, with the most recent change of +$396.10 thousand (+6.86%) on September 30, 2024.
- Over the past year, CTCX quarterly current liabilities has dropped by -$31.54 million (-83.63%).
- CTCX quarterly current liabilities is now -83.97% below its all-time high of $38.50 million, reached on December 31, 2023.
Performance
CTCX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CTCX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +427.8% | -83.6% |
| 3 y3 years | +143.6% | -15.4% |
| 5 y5 years | +143.6% | -15.4% |
CTCX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +427.8% | -84.0% | +50.2% |
| 5 y | 5-year | at high | +427.8% | -84.0% | +50.2% |
| alltime | all time | at high | +427.8% | -84.0% | +50.2% |
Carmell Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.17 M(+6.9%) |
| Jun 2024 | - | $5.78 M(-16.3%) |
| Mar 2024 | - | $6.91 M(-82.1%) |
| Dec 2023 | $38.50 M | $38.50 M(+2.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $37.71 M(+817.5%) |
| Jun 2023 | - | $4.11 M(-43.7%) |
| Dec 2022 | $7.30 M(-53.8%) | $7.30 M |
| Dec 2021 | $15.80 M | - |
FAQ
- What is Carmell Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Carmell Therapeutics?
- What is Carmell Therapeutics annual current liabilities year-on-year change?
- What is Carmell Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Carmell Therapeutics?
- What is Carmell Therapeutics quarterly current liabilities year-on-year change?
What is Carmell Therapeutics annual total current liabilities?
The current annual current liabilities of CTCX is $38.50 M
What is the all time high annual current liabilities for Carmell Therapeutics?
Carmell Therapeutics all-time high annual total current liabilities is $38.50 M
What is Carmell Therapeutics annual current liabilities year-on-year change?
Over the past year, CTCX annual total current liabilities has changed by +$31.21 M (+427.77%)
What is Carmell Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of CTCX is $6.17 M
What is the all time high quarterly current liabilities for Carmell Therapeutics?
Carmell Therapeutics all-time high quarterly total current liabilities is $38.50 M
What is Carmell Therapeutics quarterly current liabilities year-on-year change?
Over the past year, CTCX quarterly total current liabilities has changed by -$31.54 M (-83.63%)